Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 245.62%37.5K | -19.55%13.87K | 23.28%24.21K | -21.99%99.16K | 5.67%51.43K | -62.91%10.85K | -27.36%17.24K | -22.83%19.64K | -65.10%127.11K | -19.23%48.67K |
| Selling and administrative expenses | 253.07%37.5K | -19.55%13.87K | 23.28%24.21K | -21.42%98.93K | 5.72%51.43K | -63.51%10.62K | -27.36%17.24K | -19.51%19.64K | -65.43%125.9K | -19.27%48.65K |
| -General and administrative expense | 253.07%37.5K | -19.55%13.87K | 23.28%24.21K | -21.42%98.93K | 5.72%51.43K | -63.51%10.62K | -27.36%17.24K | -19.51%19.64K | -65.43%125.9K | -19.27%48.65K |
| Other operating expenses | ---- | ---- | ---- | -80.94%230 | -96.00%1 | 53.69%229 | ---- | ---- | --1.21K | --25 |
| Operating profit | -245.62%-37.5K | 19.55%-13.87K | -23.28%-24.21K | 21.99%-99.16K | -5.67%-51.43K | 62.91%-10.85K | 27.36%-17.24K | 22.83%-19.64K | 65.10%-127.11K | 19.23%-48.67K |
| Net non-operating interest income (expenses) | ||||||||||
| Other net income (expenses) | -100.05%-4 | -100.03%-7 | 5,532.21%250.26K | 110.27%4.07K | -187.47%-21.27K | 199.44%8.15K | 241.63%21.8K | 46.65%-4.61K | 31.85%-39.62K | -2,256.85%-7.4K |
| Gain on sale of security | -100.10%-8 | 99.91%-2 | 103.99%208 | -399.94%-18.72K | -511.62%-19.44K | 292.76%8.14K | -142.74%-2.21K | -994.34%-5.21K | 140.06%6.24K | 108.89%4.72K |
| Special income (charges) | 300.00%4 | --0 | --0 | 149.69%22.79K | 84.94%-1.83K | 100.03%1 | 216.80%24K | 106.58%607 | -7.75%-45.86K | -531.96%-12.12K |
| -Less:Impairment of capital assets | --0 | --0 | --0 | --0 | -91.76%612 | ---1 | ---4 | ---607 | --7.43K | --7.43K |
| -Less:Other special charges | -104.17%-4 | ---- | ---- | -96.84%1.21K | -87.02%609 | -97.58%96 | -98.95%216 | -96.82%293 | -9.70%38.43K | 144.58%4.69K |
| -Less:Write off | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | --0 | --0 | ---- | --24K | --0 | --0 | --24K | ---- | --0 | ---- |
| Other non-operating income (expenses) | ---- | ---5 | --250.05K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -1,286.83%-37.5K | -404.21%-13.88K | 1,032.37%226.05K | 42.97%-95.09K | -29.66%-72.7K | 92.78%-2.7K | 111.66%4.56K | 28.87%-24.25K | 60.52%-166.72K | 6.42%-56.07K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -1,286.83%-37.5K | -404.21%-13.88K | 1,032.37%226.05K | 42.97%-95.09K | -29.66%-72.7K | 92.78%-2.7K | 111.66%4.56K | 28.87%-24.25K | 60.52%-166.72K | 6.42%-56.07K |
| Net income continuous operations | -1,286.83%-37.5K | -404.21%-13.88K | 1,032.37%226.05K | 42.97%-95.09K | -29.66%-72.7K | 92.78%-2.7K | 111.66%4.56K | 28.87%-24.25K | 60.52%-166.72K | 6.42%-56.07K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -1,286.83%-37.5K | -404.21%-13.88K | 1,032.37%226.05K | 42.97%-95.09K | -29.66%-72.7K | 92.78%-2.7K | 111.66%4.56K | 28.87%-24.25K | 60.52%-166.72K | 6.42%-56.07K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -1,286.83%-37.5K | -404.21%-13.88K | 1,032.37%226.05K | 42.97%-95.09K | -29.66%-72.7K | 92.78%-2.7K | 111.66%4.56K | 28.87%-24.25K | 60.52%-166.72K | 6.42%-56.07K |
| Diluted earnings per share | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 66.67%-0.01 | 59.97%-0.004 |
| Basic earnings per share | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 66.67%-0.01 | 59.97%-0.004 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.